What are the various types of renal transplantation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Types of Renal Transplantation

Renal transplantation is classified into two main categories based on donor source: deceased-donor (cadaveric) transplantation and living-donor transplantation, with multiple subcategories and specialized approaches within each type 1, 2.

Primary Classification by Donor Source

Living-Donor Transplantation

Living-donor kidney transplantation represents the ideal mechanism for transplant recipients, offering superior outcomes compared to deceased-donor organs 2. This category includes:

  • HLA-identical (related) transplants: Typically from siblings or parents with matching human leukocyte antigens, achieving approximately 95% 2-year graft survival 3
  • Living-related transplants: From biologically related donors with varying degrees of HLA matching, showing approximately 85% 2-year graft survival 3
  • Living-unrelated transplants: From spouses, friends, or altruistic donors

Deceased-Donor (Cadaveric) Transplantation

Cadaveric kidney transplants achieve approximately 75% 2-year graft survival 3. These can be further categorized by:

  • Standard criteria donors: Younger donors with optimal organ quality
  • Extended criteria donors: Donors over 65 years old, which show similar short-term results to younger organs but require minimized cold ischemia time 1

Specialized Transplantation Approaches

Kidney Exchange Programs

Kidney exchange transplantation has evolved from simple 2-way exchanges to highly complex multi-way arrangements 4. These programs address incompatibility issues including:

  • ABO blood group incompatibility: Traditional practice requires ABO compatibility 5, though A2 donors can sometimes be used for O recipients 5
  • Immunological incompatibility: Positive crossmatch or donor-specific antibodies
  • HLA incompatibility: Poor HLA matching scenarios

Exchange configurations include 4:

  • Traditional simultaneous 2-way exchanges
  • 3-way, 4-way, and n-way exchanges
  • Non-simultaneous kidney exchanges
  • Never-ending altruistic donor chains
  • Domino chains
  • Single-center, multicenter, regional, national, and international exchanges

Combined Approaches

Modern transplantation includes hybrid strategies 4:

  • Kidney exchange combined with desensitization protocols
  • Kidney exchange combined with ABO-incompatible transplantation
  • Living donor-deceased donor list exchanges

Histocompatibility Considerations

Donors and recipients should be matched as closely as possible for HLA-A, -B, and -DR antigens to improve long-term outcomes 5. Key principles include:

  • ABO compatibility: Blood group of recipient must be compatible with donor 5
  • HLA matching: Optimum matching reduces acute rejection and improves long-term graft survival 5
  • Molecular genotyping: Strongly recommended for African American candidates due to 36.3% serotyping discrepancy rates 5

Important Caveat

Efforts to transplant kidneys from ABO-incompatible donors should be considered experimental 5, though some centers use antibody removal strategies to enable such transplants 5.

Surgical Approach Classification

From a technical perspective 6:

  • First or second single kidney transplants: Open kidney transplantation remains the standard surgical approach
  • Third or further transplants: Require preoperative planning to ensure adequate arterial inflow, venous outflow, and space for the new kidney 6

The choice between living-donor and deceased-donor transplantation significantly impacts outcomes, with living donation offering better graft survival, cost-effectiveness, and allowing for normal lifestyle while reducing dialysis-related mortality risks 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.